Acadia Pharmaceuticals (ACAD) Invested Capital (2010 - 2012)
Acadia Pharmaceuticals (ACAD) posted Invested Capital of $17.6 million for Q1 2012, down 24.74% on a QoQ basis from $23.4 million in Q4 2011.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Invested Capital (2010 - 2012) Analysis & Trends
Acadia Pharmaceuticals has reported Invested Capital for 3 years, with the latest figure at $17.6 million in Q1 2012.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $17.6 million in Q1 2012; TTM through Mar 2012 was $17.6 million, a N/A change from a year earlier, with the FY2011 full-year figure at $23.4 million, down 21.41% from the prior year.
- Invested Capital was $17.6 million for Q1 2012 at Acadia Pharmaceuticals, down from $23.4 million in the prior quarter.
- The five-year high for Invested Capital was $32.9 million in Q2 2011, with the low at $17.6 million in Q1 2012.
- Average Invested Capital over 3 years is $26.4 million, with a median of $28.2 million recorded in 2011.
- The largest YoY upside for Invested Capital was 21.41% in 2011 against a maximum downside of 21.41% in 2011.
- Over 3 years, Invested Capital stood at $29.8 million in 2010, then dropped by 21.41% to $23.4 million in 2011, then decreased by 24.74% to $17.6 million in 2012.
- The last three Invested Capital figures came in at $17.6 million (Q1 2012), $23.4 million (Q4 2011), and $28.2 million (Q3 2011), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 145.70 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 159.97 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 51.53 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 74.44 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 40.49 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2012 | 17.61 Mn |
| Dec 31, 2011 | 23.39 Mn |
| Sep 30, 2011 | 28.18 Mn |
| Jun 30, 2011 | 32.86 Mn |
| Dec 31, 2010 | 29.77 Mn |
API Access
Acadia Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();